A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
Purpose and significance:With the increasing incidence of Diabetes mellitus (DM), the incidence rate of Diabetic Foot (DF) is raised. DF is a foot infection, ulceration and / or deep tissue destruction caused by nerve abnormalities and varying degrees of vascular lesions in DM patients. The high incidence, disability and mortality rate of DF make it urgent to explore new ways to improve the cure rate, reduce the burden and elevate the quality of life. Previous studies have confirmed that traditional Miao ethic medicine Tangningtongluo(TNTL) can improve the remission rate of diabetes mellitus and diabetic foot disease, but the clinical research evidence is not sufficient. This study aims to provide effective clinical evidence for the treatment of diabetic foot patients with TNTL by observing growth rate of wound, prognosis and outcome.
Methods: From September 2021 to March 2023, a total of 80 diabetic foot ulcer patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Participants are randomized in a ratio of 1: 1: 1:1 into four treatment groups of 20 participants: (i) standardized western medicine treatment group, (ii) standardized western medicine treatment+TNTL tablet+TNTL cream group , (iii) standardized western medicine treatment+TNTL tablet group, and (iiii) standardized western medicine treatment+TNTL cream group. Treatment with TNTL tablets: the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, islet-specific autoantibodies(ISAs), fat mass, and islet β-cell function were measured. The healing stage of the wound surface and the growth degree of granulation tissue were graded, and the time required for wound repairing to each healing stage was observed.
Type of study: randomized controlled, prospective,intervention study.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Registrering (Forventet)
Fase
- Fase 1
Kontakter og plasseringer
Studiesteder
-
-
Jiangsu
-
Nantong, Jiangsu, Kina, 226001
- Rekruttering
- Gu Yunjuan
-
Ta kontakt med:
- Gu Yunjuan, M.D/Ph.D
- Telefonnummer: +8615851207860
- E-post: desette@ntu.edu.cn
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Clinical diagnosis of Type 2 diabetes mellitus
- Clinical diagnosis of Diabetic Foot Ulcer
Exclusion Criteria:
- Type 1 diabetes mellitus(T1DM), special type of diabetes, gestational diabetes mellitus, drug-induced hyperglycemia
- TNTL allergy
- Chronic kidney failure（eGFR≤30ml/min/1.73cm2）, severe liver function damage (transaminase ≥ 3 times the normal value), acute or chronic pancreatitis, autoimmune disease, malignant tumors
- Recent acute complications of type 2 diabetes mellitus（ketoacidosis, hyperosmolar nonketotic diabetic coma, lactic acidosis etc.）or other emergency situations
- History of using glucocorticoids and immunosuppressants
- Mental illness and cognitive dysfunction or poor compliance, unable to take medication as required
- Malignant ulcer
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Standardized Western Medicine Treatment Group
All participants undergo a similar treatment protocol for the diabetic foot, based on the Infectious Diseases Society of America (IDSA).
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Andre navn:
|
|
Eksperimentell: Standardized Western Medicine Treatment +TNTL tablet+TNTL cream Group
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.
Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Andre navn:
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc.
It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.There are two dosage forms: tablet and cream.
Andre navn:
|
|
Eksperimentell: Standardized Western Medicine Treatment +TNTL tablet Group
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Andre navn:
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc.
It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use tablet.
Andre navn:
|
|
Eksperimentell: Standardized Western Medicine Treatment +TNTL cream Group
Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Andre navn:
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc.
It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use cream.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Decrease area of wound healing due to Diabetic Foot Ulcer
Tidsramme: 12 weeks
|
Assessment the decrease of whole area of diabetic foot ulcers.
The unit is square centimeters .
|
12 weeks
|
|
Decrease of depth of ulcer involve the deep fascia.
Tidsramme: 12 weeks
|
Measurement of depth of ulcer involve the deep fascia.
The unit is millimeters.
|
12 weeks
|
|
Amputation Rate
Tidsramme: 12 weeks
|
The difference of end-stage amputation rates between the experimental group and the control group were evaluated by the arterial and venous blood circulation of the lower limbs
|
12 weeks
|
|
Diabetic Foot Ulcer relapse rate
Tidsramme: 12 weeks
|
The relapse of Diabetic Foot Ulcers is a common complication in the advanced stage of DFU.
The difference of treatment between the experimental group and the control group indicates that the prognosis is variability.
|
12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Fasting glucose
Tidsramme: 12 weeks
|
10 hours after fasting peripheral blood glucose level, and the unit is mmol/L
|
12 weeks
|
|
2-H postload glucose
Tidsramme: 12 weeks
|
2 hours after peripheral blood glucose level eating 75g glucose or 100g steamed bread, and the unit is mmol/L
|
12 weeks
|
|
BMI Index
Tidsramme: 12 weeks
|
The calculation formula of Body Mass Index is: BMI = weight ÷ height 2. (weight in kilograms; height in meters.)
|
12 weeks
|
|
WHR Index
Tidsramme: 12 weeks
|
Waist to hip ratio (WHR) = waist / hip.Waist circumference or minimum waist circumference shall be used for measurement, and evaluation of WHR is an important value to central obesity.
|
12 weeks
|
|
Islet B cell function
Tidsramme: 12 weeks
|
The ability of islet B cells to secrete insulin was reflected by the level of C peptide, which is measured after fasting.
The unit is ng/dL .
|
12 weeks
|
|
interleukin-6(IL-6)
Tidsramme: 12 weeks
|
Determine the level of interleukin-6(IL-6) in peripheral blood by ELISA, the unit is ng/L.
|
12 weeks
|
|
tumour necrosis factor-α(TNF-α)
Tidsramme: 12 weeks
|
Determine the level of TNF-α in peripheral blood , the unit is ng/ml.
|
12 weeks
|
|
C-reactive protein(CRP)
Tidsramme: 12 weeks
|
Determine the level of C-reactive protein(CRP) in peripheral blood , the unit is μg/L.
|
12 weeks
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TNTL on diabetic foot ulcer
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Diabetisk fotsår
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRekruttering
-
Assiut UniversityUkjentom Vitreomacular Interface Abnormalities in Diabetic Retinopathy
-
Sahlgrenska University Hospital, SwedenFullførtDiabetisk fot | Diabetisk fotsår | Fotdeformiteter | Nevropati; perifert | Diabetisk fotsår Nevropatisk | Foot callusSverige